An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma
Cell Reports · 2024-01 · 43 (1) · 113557
DOI: 10.1016/j.celrep.2023.113557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-01. Verfasst von Stephanie M Casillo und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. Hauptthemen laut MEDLINE: Glioma, Histones. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Metabolic reprogramming in pediatric diffuse midline glioma is driven by gene expression changes induced by the hallmark histone mutation H3K27M, which results in aberrantly permissive activation of oncogenic signaling pathways. Previous studies of diffuse midline glioma with altered H3K27 (DMG-H3K27a) have shown that the RAS pathway, specifically through its downstream kinase, extracellular-signal-related kinase 5 (ERK5), is critical for tumor growth. Further downstream effectors of ERK5 and their role in DMG-H3K27a metabolic reprogramming have not been explored. We establish that ERK5 is a critical regulator of cell proliferation and glycolysis in DMG-H3K27a. We demonstrate that ERK5 mediates glycolysis through activation of transcription factor MEF2A, which subsequently modulates expression of glycolytic enzyme PFKFB3. We show that in vitro and mouse models of DMG-H3K27a are sensitive to the loss of PFKFB3. Multi-targeted drug therapy against the ERK5-PFKFB3 axis, such as with small-molecule inhibitors, may represent a promising therapeutic approach in patients with pediatric diffuse midline glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
- Department of Pediatric Hematology and Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN 38105, USA.
- Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
- Division of Hematology Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pittsburgh, PA 15261, USA; Division of Hematology Oncology, Department of Pediatrics, Albany Medical College, Albany, NY 12208, U…
- Department of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; University of California, Santa Cruz Genomics Institute, Santa Cruz, CA 95064, USA.
- Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Förderung
- NINDS NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- NIH HHS
Zitieren
APA
Casillo, S. M., Gatesman, T. A., Chilukuri, A., Varadharajan, S., Johnson, B. J., David Premkumar, D. R., Jane, E. P., Plute, T. J., Koncar, R. F., Stanton, A. J., Biagi-Junior, C. A. O., Barber, C. S., Halbert, M. E., Golbourn, B. J., Halligan, K., Cruz, A. F., Mansi, N. M., Cheney, A., Mullett, S. J., …, & Agnihotri, S. (2024). An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma. Cell Reports, 43(1), 113557. https://doi.org/10.1016/j.celrep.2023.113557
Vancouver
Casillo SM, Gatesman TA, Chilukuri A, Varadharajan S, Johnson BJ, David Premkumar DR, et al. An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma. Cell Reports. 2024;43(1):113557. doi:10.1016/j.celrep.2023.113557
BibTeX
@article{Casillo2024,
author = {Casillo, Stephanie M and Gatesman, Taylor A and Chilukuri, Akanksha and Varadharajan, Srinidhi and Johnson, Brenden J and David Premkumar, Daniel R and Jane, Esther P and Plute, Tritan J and Koncar, Robert F and Stanton, Ann-Catherine J and Biagi-Junior, Carlos A O and Barber, Callie S and Halbert, Matthew E and Golbourn, Brian J and Halligan, Katharine and Cruz, Andrea F and Mansi, Neveen M and Cheney, Allison and Mullett, Steven J and Land, Clinton Van't and Perez, Jennifer L and Myers, Max I and Agrawal, Nishant and Michel, Joshua J and Chang, Yue-Fang and Vaske, Olena M and MichaelRaj, Antony and Lieberman, Frank S and Felker, James and Shiva, Sruti and Bertrand, Kelsey C and Amankulor, Nduka and Hadjipanayis, Costas G and Abdullah, Kalil G and Zinn, Pascal O and Friedlander, Robert M and Abel, Taylor J and Nazarian, Javad and Venneti, Sriram and Filbin, Mariella G and Gelhaus, Stacy L and Mack, Stephen C and Pollack, Ian F and Agnihotri, Sameer},
title = {An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {1},
pages = {113557},
doi = {10.1016/j.celrep.2023.113557}
}
EUVIMED